A new stability indicating HPLC method for related substances in zolmitriptan

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 1, 2010, Pages 119-122

  Vijayakumar, E K S ^a   Samel, M A ^a   Bhalekar, S B ^a   Pakhale, S M ^a,b  

^a Mylan India Pvt Ltd   (India)

^b Glenmark Pharmaceuticals Limited   (India)

Author keywords

Forced degradation; HPLC; Method development; Related substances; Zolmitriptan

Indexed keywords

ZOLMITRIPTAN;

ARTICLE; CHEMICAL STRUCTURE; DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 77951670375     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.62252     Document Type: Article

References (18)

1. Oldman AD, Smith LA, McQuay HJ, Moore RA. A systematic review of treatments for acute migraine. Pain 2002;97:247-257
2. Yates R, Nairn K, Dixon R, Seaber E. Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. J Clin Pharmacol 2002;42:1237-1243
3. Yates R, Nairn K, Dixon R, Kemp JV, Dane AL. Pharmacokinetics, dose proportionality and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers. J Clin Pharmacol 2002;42:1244-1250
4. Chen X, Liu D, Luan Y, Jin F, Zhong D. Determination of zolmitriptan in human plasma by liquid chromatography-tandem mass spectrometry method: Application to a pharmacokinetic study. J Chromatogr B 2006;832:30-35 (Pubitemid 43213006)
5. Yu L, Wen Y, Song Z, Mu D, Su L, Yang Y. Determination of zolmitriptan and its pharmacokinetics in human plasma after intranasal administration using LC-MS. Fenxi Ceshi Xuebao 2006;25:67-70.
6. He H, Meng H, Zhou Y, Li B, Li X. Determination of zolmitriptan in human plasma by RP-HPLC with liquid-liquid extraction. Yaowu Fenxi Zazhi 2005;25:323-325
7. Yao J, Qu Y, Zhao X, Hu L, Zhu R, Li H, et al. Determination of zolmitriptan in human plasma by high performance liquid chromatography- electrospray mass spectrometry and study on its pharmacokinetics. J Chinese Pharm Sci 2005;14:25-28
8. Zang Z, Xu F, Tian Y, Li W, Mao G. Quantifi cation of zolmitriptan in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004;813:227-233
9. Chen J, Jiang X, Jiang W, Mei N, Gao X, Zhang Q. High performance liquid chromatographic analysis of zolmitriptan in human plasma using fl uorescence detection. J Pharm Biomed Anal 2004;35:639-645
10. Clement EM, Franklin M. Simultaneous measurement of zolmitriptan and its major metabolites N-desmethylzolmitriptan and zolmitriptan N-oxide in human plasma by high-performance liquid chromatography with coulometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 2002;766:339-343
11. Kilic B, Özden T, Toptan S, Özilhan S. Simultaneous LC-MS-MS determination of zolmitriptan and its active metabolite N-desmethylzolmitriptan in human plasma. Chromatographia 2007;66:129-133
12. Hu Y, Yao T, Wang X. HPLC determination of zolmitriptan and its related substances. Zhejiang Daxue Xuebao, Yixueban 2004;33:37-40.
13. Srinivasu MK, Mallikarjuna Rao B, Sridhar G, Rajender Kumar P, Chandra Sekhar KB, Aminul I. A validated chiral LC method for the determination of zolmitriptan and its potential impurities. J Pharm Biomed Anal 2005;37:453-460 (Pubitemid 40312288)
14. Mallikarjuna Rao B, Srinivasu MK, Sridhar G, Rajender Kumar P, Chandra Sekhar KB, Aminul I. A stability indicating LC method for zolmitriptan. J Pharm Biomed Anal 2005;39:503-509
15. Gore VG, Datta D, Gadkar MS, Pokharkar KS, Phatangare K. A convenient process (Zolmitriptan). PCT Appl No PCT/GB2008/050906 dt. 03/10/08.
16. Q1A (R2), ICH Harmonized Tripartite Guideline, Geneva, Switzerland: February 2003.
17. Q2A, ICH Harmonized Tripartite Guideline, Geneva, Switzerland: October 1994.
18. Q2B, ICH Harmonized Tripartite Guideline, Geneva, Switzerland: November 1996.